FULC Option Overview

Fulcrum Therapeutics Inc (FULC) options traded 5 contracts on Nov 17, 2026, well below the 20-day average of 43.

About FULC

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell dis...
Employees
55
Headquarters
Cambridge, MA
IPO Date
2019
Market Cap
$283.38M
Dividend Yield
—
Average Volume
1.32M
High Today
$3.85
Low Today
$3.72
Open Price
$3.73
Volume
1.13M
52 Week High
$15.74
52 Week Low
$2.83
Implied Volatility (30d)
%
IV Rank
-
IV Percentile
-
Historical Volatility
20.38%
IV Low
25.42% on 08/17/26
IV High
281.94% on 09/21/26
Today's Open Interest
18,607
Put-Call Ratio
0.71
Put Open Interest
7,728
Call Open Interest
10,879
Open Interest Avg (30-day)
18,282
Today vs Open Interest Avg (30-day)
101.78%
Today's Volume
5
Put-Call Ratio
0.00
Put Volume
5
Call Volume
0
Volume Avg (30-day)
42
Today vs Volume Avg (30-day)
11.9%

Option Chain Statistics

This table provides a comprehensive overview of all FULC options grouped by their expiration dates.

FULC Options FAQ

How actively are FULC options traded?

0 calls and 5 puts traded on Nov 17, 2026, 5 contracts in total. Over the past 30 days, volume averaged 42 contracts per day. The FULC option volume chart shows volume by strike and expiration date.

Is FULC implied volatility high right now?

Fulcrum Therapeutics IV rank is 76, so its 30-day implied volatility of 220.8% is in the upper part of its one-year range. Over the past year it ranged from 25.4% on Aug 17, 2026 to 281.9% on Sep 21, 2026. See the FULC implied volatility history for a longer view.

What is the FULC put/call ratio?

The Fulcrum Therapeutics put/call volume ratio was 0.00 on Nov 17, 2026, which signals bullish sentiment. The FULC open interest chart shows calls and puts at each strike.

What is FULC max pain this week?

As of the Nov 17, 2026 close, max pain for Fulcrum Therapeutics options about one week from expiration was $4.00, 6.7% above the $3.75 close. The FULC max pain chart shows it for every expiration date.

What is FULC's expected move over the next week?

Based on 7-day implied volatility of 501.5%, options price a move of about ±$2.60 (±69.4%) over the next week, a range of roughly $1.15 to $6.35 from the Nov 17, 2026 close. The FULC expected move chart shows it for every expiration date.

What is Fulcrum Therapeutics Inc?

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases.

Give feedback on this chart